Ken Griffin Intercure Ltd. Call Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$1.71 - $2.62 $4,617 - $7,074	-2,700 Reduced 48.21%	2,900 $5,000
Q2 2024 Aug 14, 2024	BUY	$1.97 - $3.62 $9,456 - $17,376	4,800 Added 600.0%	5,600 $11,000
Q1 2024 May 15, 2024	SELL	$1.18 - $2.71 $6,608 - $15,176	-5,600 Reduced 87.5%	800 $2,000
Q4 2023 Feb 14, 2024	SELL	$1.01 - $1.62 $3,535 - $5,670	-3,500 Reduced 35.35%	6,400 $8,000
Q3 2023 Nov 14, 2023	BUY	$1.39 - $1.72 $12,788 - $15,824	9,200 Added 1314.29%	9,900 $15,000
Q2 2023 Aug 14, 2023	SELL	$1.7 - $2.6 $170 - $260	-100 Reduced 12.5%	700 $1,000
Q1 2023 May 15, 2023	SELL	$1.81 - $4.0 $362 - $800	-200 Reduced 20.0%	800 $1,000
Q4 2022 Feb 14, 2023	BUY	$3.27 - $5.5 $3,270 - $5,500	1,000 New	1,000 $3,000

3.46M

19.5K

100

Ticker INCR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,133,900
Market Cap $67.2M
Description
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.